Topic · page 44 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 1,721–1,760 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Lupus22 Dec 2022
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis
Meta-analysis
Lupus21 Dec 2022
The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States
Cohort study
Lupus21 Dec 2022
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey
Cross-sectional study
Lupus20 Dec 2022
Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis
Meta-analysis
Arthritis Care Res (Hoboken)20 Dec 2022
Evaluating the Construct of Damage in Systemic Lupus Erythematosus
Guideline or statement
Arthritis Rheumatol16 Dec 2022
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study
Cohort study
Clin Exp Rheumatol16 Dec 2022
Serological markers of basement membrane collagen type IV and laminin are increased in systemic lupus erythematosus but differentially expressed in patients with previous cardiovascular events
Cross-sectional study
Lupus14 Dec 2022
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study
Cross-sectional study
Lupus12 Dec 2022
Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus
Cross-sectional study
Arthritis Care Res (Hoboken)12 Dec 2022
High Prevalence but Low Impact of Cognitive Dysfunction on Quality of Life in Patients With Lupus and Neuropsychiatric Symptoms
Cohort study
Rheumatology (Oxford)10 Dec 2022
Systemic lupus erythematosus incidence and prevalence in a large population-based study in northeastern Italy
Cohort study
Lupus9 Dec 2022
Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study
Cohort study
Lupus8 Dec 2022
The exploration of shared genes and molecular mechanisms of systemic lupus erythematosus and atherosclerosis
Diagnostic or prognostic study
Arthritis Care Res (Hoboken)8 Dec 2022
Predictors of Thirty‐Day Hospital Readmissions in Systemic Lupus Erythematosus in the United States: A Nationwide Study
Cohort study
Rheumatology (Oxford)8 Dec 2022
The association of trauma with self-reported flares and disease activity in systemic lupus erythematosus (SLE)
Cohort study
Clin Exp Rheumatol7 Dec 2022
Absolute risk estimation of new-onset proteinuria in patients with systemic lupus erythematosus: a Danish nationwide cohort study
Cohort study
Lupus5 Dec 2022
Influencing factors of self-disclosure and its impact on quality of life in patients with systemic lupus erythematosus
Cross-sectional study
Lupus5 Dec 2022
Different pregnancy outcomes in patients with systemic lupus erythematosus treated with belimumab
Cohort study
Lupus2 Dec 2022
Pulmonary involvement: A potential independent factor for quality of life in systemic lupus erythematosus
Cross-sectional study
Lupus2 Dec 2022
Association of podocyte injury with clinical features and prognosis in patients with mesangial proliferative lupus nephritis
Cohort study
Arthritis Care Res (Hoboken)2 Dec 2022
Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance
Cohort study
Arthritis Care Res (Hoboken)2 Dec 2022
Depressed Symptomatology in Systemic Lupus Erythematosus Patients
Cohort study
Lupus2 Dec 2022
Development of an instrument to predict proliferative histological class in lupus nephritis based on clinical and laboratory data
Cohort study
Lupus30 Nov 2022
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance
Cohort study
Lupus29 Nov 2022
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort
Cross-sectional study
Lancet Rheumatol28 Nov 2022
Identification of biomarkers to stratify response to B-cell-targeted therapies in systemic lupus erythematosus: an exploratory analysis of a randomised controlled trial
Secondary analysis
Arthritis Care Res (Hoboken)27 Nov 2022
Digital Narratives of Living With Lupus: Lived Experiences and Meanings for Latin American and Latino Patients and Their Families
Research article
Lupus26 Nov 2022
Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection
Case-control study
Arthritis Care Res (Hoboken)26 Nov 2022
Systemic Lupus Erythematosus and Mortality in Elderly Patients With Early Breast Cancer
Cohort study
Semin Arthritis Rheum25 Nov 2022
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors
Case-control study
Lupus23 Nov 2022
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study
Cohort study
Lupus23 Nov 2022
Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus
Case-control study
Lupus23 Nov 2022
Validity of immunoglobulin-binding protein 1 as a biomarker for lupus nephritis
Diagnostic or prognostic study
Lupus22 Nov 2022
Cardiac involvement in a Spanish unicentric prospective cohort of patients with systemic lupus erythematosus
Cohort study
Rheumatology (Oxford)22 Nov 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
Cross-sectional study
Semin Arthritis Rheum19 Nov 2022
Benefits & risks of physical activity in patients with Systemic Lupus Erythematosus: a systematic review of the literature
Meta-analysis
Lupus18 Nov 2022
Alexithymia in systemic lupus erythematosus: A cross sectional study in a Brazilian sample
Cross-sectional study
Lupus17 Nov 2022
Association between serum uric acid level and systemic lupus erythematosus kidney outcome: An observational study in Southern Chinese population and a meta-analysis
Meta-analysis
Arthritis Care Res (Hoboken)17 Nov 2022
Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus
Diagnostic or prognostic study
Arthritis Care Res (Hoboken)17 Nov 2022
Measuring the Impact of MyLupusGuide in Canada: Results of a Randomized Controlled Study
Randomized controlled trial

All 1,848 Briefs in ExploreShowing Briefs 1,721–1,760 of 1,848, newest first